GTPL7939 is primarily used in biochemical and pharmacological research as a selective inhibitor targeting specific signaling pathways involved in cellular proliferation and inflammation. It serves as a tool compound to study kinase enzyme activity, particularly in assays designed to evaluate potential anticancer or anti-inflammatory agents. Due to its ability to modulate intracellular signaling, it is employed in in vitro studies to investigate cell cycle regulation and apoptosis. Researchers also utilize GTPL7939 in target validation experiments to assess the therapeutic potential of inhibiting specific protein kinases in disease models. Its application remains confined to laboratory and preclinical research settings, with no current use in clinical or industrial applications.